Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide and WBRT in Lung and Breast Cancer Brain Metastases
NCT02133677Phase 2Unknown
- Sponsor
- Far Eastern Memorial Hospital
- Start
- May 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of temozolomide in brain metastasis (BM), sponsored by Far Eastern Memorial Hospital. Primary endpoint: Objective Response Rate. Status: unknown.
02
Drugs
temozolomide
03
Conditions
brain metastasis (BM)
Beyond the preview
Go deeper on NCT02133677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02133677.